Monday, November 24, 2014

MabVax Is Under The Radar, But Undervalued: CEO David Hansen

Today, I am discussing an emerging biotech company called MabVax Therapeutics (OTCQB:MBVX).
MBVX Chart
In order to gain more insight, I conducted an email interview with David Hansen, President and CEO of MabVax.

No comments:

Post a Comment